Stifel, Intel
Danaher price target lowered to $260 from $265 at Stifel
Stifel lowered the firm’s price target on Danaher (DHR) to $260 from $265 and keeps a Hold rating on the shares. Danaher being conservative with the initial FY25 outlook was “not a surprise for many,” but numbers themselves combined with “a rare EPS miss,
Stifel Financial Corporation reported earnings for the fourth quarter of 2024, significantly surpassing analyst expectations.
Stifel chief executive Ron Kruszewski said surging markets have forced firms to be particularly choosy about which advisors ...
The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...
Shares of Stifel Financial were moving higher after it reported fourth-quarter adjusted earnings that beat Wall Street ...
Stifel Nicolaus analyst Matthew Smith, CFA maintained a Buy rating on Altria Group (MO – Research Report) today and set a price target of ...
The team of three advisors have started a firm called T6 Wealth Management, which will operate out of Morgan Stanley's new ...
Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $125.6, a high estimate of $135.00, and a low estimate of $115.00. This upward trend is evident, ...
In a report released today, Ruben Roy from Stifel Nicolaus maintained a Buy rating on Viavi Solutions (VIAV – Research Report), with a price ...
Q4 2024 Earnings Conference Call January 29, 2025 9:30 AM ETCompany ParticipantsJoel Jeffrey - Senior Vice President ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback